Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding

Daniel Miotto Dupont, Jeppe Buur Madsen, Roland Karl Hartmann, Bertrand Tavitian, Frédéric Ducongé, Jørgen Kjems, Peter André Andreasen

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

    21 Citations (Scopus)

    Abstract

    The serine proteinase urokinase-type plasminogen activator (uPA) is widely recognized as a potential target for anticancer therapy. Its association with cell surfaces through the uPA receptor (uPAR) is central to its function and plays an important role in cancer invasion and metastasis. In the current study, we used systematic evolution of ligands by exponential enrichment (SELEX) to select serum-stable 2'-fluoro-pyrimidine-modified RNA aptamers specifically targeting human uPA and blocking the interaction to its receptor at low nanomolar concentrations. In agreement with the inhibitory function of the aptamers, binding was found to be dependent on the presence of the growth factor domain of uPA, which mediates uPAR binding. One of the most potent uPA aptamers, upanap-12, was analyzed in more detail and could be reduced significantly in size without severe loss of its inhibitory activity. Finally, we show that the uPA-scavenging effect of the aptamers can reduce uPAR-dependent endocytosis of the uPA-PAI-1 complex and cell-surface associated plasminogen activation in cell culture experiments. uPA-scavenging 2'-fluoro-pyrimidine-modified RNA aptamers represent a novel promising principle for interfering with the pathological functions of the uPA system.
    Original languageEnglish
    JournalRNA
    Volume16
    Issue12
    Pages (from-to)2360-9
    Number of pages10
    ISSN1355-8382
    DOIs
    Publication statusPublished - 1 Dec 2010

    Keywords

    • Antineoplastic Agents
    • Aptamers, Nucleotide
    • Base Sequence
    • Drug Screening Assays, Antitumor
    • Drug Stability
    • Endocytosis
    • Humans
    • Molecular Sequence Data
    • Multiprotein Complexes
    • Plasminogen Activator Inhibitor 1
    • Protein Binding
    • Protein Structure, Tertiary
    • Receptors, Urokinase Plasminogen Activator
    • Serum
    • Substrate Specificity
    • Urokinase-Type Plasminogen Activator

    Fingerprint

    Dive into the research topics of 'Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding'. Together they form a unique fingerprint.

    Cite this